- Dapagliflozin Has Similar Efficacy for Heart Failure Globally
- Reduced-Dose Rivaroxaban Dangerous in Older Patients With Non-Valvular AF
- 37% Diagnosed With Type 1 Diabetes After Age 30
- Heat-Related Deaths Could Break Records This Year in Phoenix, America’s Hottest City
- Blue Light Glasses Unlikely to Improve Eye Strain, Sleep Quality in Adults
- Treatment Failure in Hospital-Acquired Pneumonia More Likely With Morbid Obesity
- Long-Term Artificial Sweetener Intake Linked to Risk for Obesity
- Multidisciplinary Teams Improve Outcomes in Patients With Infective Endocarditis
- Frailty Burden Effects Efficacy of Cardioverter-Defibrillator in HFrEF
- Atrial Fibrillation and Arrhythmias Common in Cardiac Sarcoidosis
- Cardiac Rehab Barriers Vary Globally According to Region
- Novel Model Aids Prediction of Survival in Heart Failure With Reduced Ejection Fraction
Features
More features
Clinical Tools
Powered by
Powered by 
